Cancer Treatment

Autologous Immune Enhancement Therapy (AIET) in Oncology

In the multi-prolonged approach to treat cancer, the latest scientific advancement has yielded AIET. Consequently, patients with cancer can choose non-toxic therapies like AIET, also known as, Biological therapy. AIET has a successful clinical history in Japan for the past two decades.

AIET is a safe and effective mode to fight cancer by enhancing the immune system. The efficacy rate is further enhanced when AIET is combined with the present available therapies as per patient's condition, type of cancer and regimen of chemo/ radio therapies.

AIET and Cancer:
Activated immune cells have the ability to recognize cancer cells and kill them. A single NK cell can destroy up to 27 cancer cells before it dies.

Dosage Requirements:
The patient may require multiple transfusions depending on the clinicians advise and patient's condition (i.e. type & stage of cancer, patient's health status and medication).

Good results have been noted in:
-Renal Cancer (Kidney)
-Malignant Melanoma (Skin)
-Advanced Pancreatic Tumors
-Leukemia (Blood Cancer)
-Lymphoma
-Breast Cancer
-Ovarian Cancer
-Lung Metastasis

Procedure for Autologous Immune Enhancement Therapy


Quality Control at NiSCELL:
The following tests are performed to ensure the safety of Immune Cells before transfusion.
1. Microbial Screening for bacterial and fungal contamination
2. Endotoxin Test for harmful endotoxins.
3. Immunophenotyping to quantify Immune Cells.

Stringent current Good Manufacturing Practice (cGMP) protocols and quality control systems are followed.